<p><strong>万嘉集团控股有限公司</strong> (HKG:401) 的股价在过去一个月回落了 27%，扭转了其近期良好的表现。好消息是，在过去一年中，该股票表现出色，涨幅达 116%。</p>
<p>在经历如此大幅的价格下跌后，考虑到香港医疗行业近一半的公司市销率（或称 &#34;P/S&#34;）超过 1 倍，您可能会认为万嘉集团控股是一个值得关注的股票，其市销率为 0.4 倍。然而，市销率低可能是有原因的，需要进一步调查以确定是否合理。</p>
<p>人工智能即将改变医疗行业。这 20 只股票正在从早期诊断到药物发现等各个方面进行探索。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前布局。</p>
<p>查看我们对万嘉集团控股的最新分析</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/247830455-ps-multiple-vs-industry-1-dark-2/1766886073981?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/247830455-ps-multiple-vs-industry-1-dark-2/1766886073981"/></p>
<p>SEHK:401 市销率与行业比较 2025 年 12 月 28 日</p>
<h3>万嘉集团控股的市销率对股东意味着什么？</h3>
<p>例如，万嘉集团控股近期收入的下降值得深思。或许市场认为近期的收入表现不足以跟上行业，导致市销率受到影响。看好万嘉集团控股的人希望这不是事实，以便他们能够以较低的估值买入该股票。</p>
<p>想要了解公司收益、收入和现金流的完整情况吗？那么我们 <strong>免费的</strong> 万嘉集团控股报告将帮助您了解其历史表现。</p>
<h2>收入预测是否与低市销率相匹配？</h2>
<p>您唯一会真正感到舒适的情况是，当公司的增长预计将落后于行业时，才会看到像万嘉集团控股这样低的市销率。</p>
<p>在回顾过去一年的财务数据时，我们感到沮丧，因为公司的收入下降了 4.5%。这意味着在长期内收入也出现了下滑，过去三年总收入下降了 6.3%。因此，可以公平地说，最近的收入增长对公司来说是不理想的。</p>
<p>与行业相比，预计在未来 12 个月内将实现 9.2% 的增长，该公司的近期中期收入结果显示出下行趋势，形成了一个令人警醒的局面。</p>
<p>考虑到这一点，我们理解为什么万嘉集团控股的市销率低于大多数行业同行。然而，我们认为收入的萎缩不太可能在长期内导致稳定的市销率，这可能使股东面临未来的失望。如果公司不改善其收入增长，市销率甚至可能降至更低水平。</p>
<h2>我们可以从万嘉集团控股的市销率中学到什么？</h2>
<p>万嘉集团控股最近疲软的股价使其市销率低于其他医疗公司。虽然市销率不应成为您是否购买股票的决定性因素，但它是收入预期的一个相当有效的晴雨表。</p>
<p>正如我们所怀疑的，我们对万嘉集团控股的审查显示，其中期收入的萎缩正在导致其市销率低，考虑到行业预计将增长。目前，股东接受低市销率，因为他们承认未来的收入可能也不会带来任何令人愉快的惊喜。如果近期的中期收入趋势持续下去，在这种情况下，很难看到股价在短期内有强劲的波动。</p>
<p>此外，您还应该了解我们发现的 <strong>万嘉集团控股的 3 个警示信号</strong>。</p>
<p>如果这些 <strong>风险让您重新考虑对万嘉集团控股的看法</strong>，请查看我们的高质量股票互动列表，以了解还有哪些其他选择。</p>
<p>移动基础设施用于国防和灾难</p>
<p>下一波机器人技术不是类人型的。它是完全自主的塔楼，在 30 分钟内提供 5G、ISR 和雷达，随时随地。</p>
<p>在下一轮合同之前获取投资者简报</p>
<p>代表 CiTech 赞助</p>

万嘉集团

<p>万嘉集团控股有限公司的股票在过去一个月下跌了 27%，尽管过去一年上涨了 116%。该公司的市销率为 0.4 倍，低于行业平均水平的 1 倍以上，反映出其收入的下降，去年下降了 4.5%，三年来下降了 6.3%。这一下降与行业预期的 9.2% 的增长形成对比，暗示该股票的估值可能面临未来的挑战</p>

<p><strong>Wanjia Group Holdings Limited</strong> (HKG:401) shares have retraced a considerable 27% in the last month, reversing a fair amount of their solid recent performance. The good news is that in the last year, the stock has shone bright like a diamond, gaining 116%.</p>
<div class="lb-trans"><p><strong>万嘉集团控股有限公司</strong> (HKG:401) 的股价在过去一个月回落了 27%，扭转了其近期良好的表现。好消息是，在过去一年中，该股票表现出色，涨幅达 116%。</p>
</div><p>After such a large drop in price, when close to half the companies operating in Hong Kong's Healthcare industry have price-to-sales ratios (or &#34;P/S&#34;) above 1x, you may consider Wanjia Group Holdings as an enticing stock to check out with its 0.4x P/S ratio. However, the P/S might be low for a reason and it requires further investigation to determine if it's justified.</p>
<div class="lb-trans"><p>在经历如此大幅的价格下跌后，考虑到香港医疗行业近一半的公司市销率（或称 &#34;P/S&#34;）超过 1 倍，您可能会认为万嘉集团控股是一个值得关注的股票，其市销率为 0.4 倍。然而，市销率低可能是有原因的，需要进一步调查以确定是否合理。</p>
</div><p>AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.</p>
<div class="lb-trans"><p>人工智能即将改变医疗行业。这 20 只股票正在从早期诊断到药物发现等各个方面进行探索。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前布局。</p>
</div><p>See our latest analysis for Wanjia Group Holdings</p>
<div class="lb-trans"><p>查看我们对万嘉集团控股的最新分析</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/247830455-ps-multiple-vs-industry-1-dark-2/1766886073981" alt="" original-src="https://images.simplywall.st/asset/chart/247830455-ps-multiple-vs-industry-1-dark-2/1766886073981"/></p>
<p>SEHK:401 Price to Sales Ratio vs Industry December 28th 2025</p>
<div class="lb-trans"><p>SEHK:401 市销率与行业比较 2025 年 12 月 28 日</p>
</div><h3>What Does Wanjia Group Holdings' P/S Mean For Shareholders?</h3>
<div class="lb-trans"><h3>万嘉集团控股的市销率对股东意味着什么？</h3>
</div><p>For instance, Wanjia Group Holdings' receding revenue in recent times would have to be some food for thought. Perhaps the market believes the recent revenue performance isn't good enough to keep up the industry, causing the P/S ratio to suffer. Those who are bullish on Wanjia Group Holdings will be hoping that this isn't the case so that they can pick up the stock at a lower valuation.</p>
<div class="lb-trans"><p>例如，万嘉集团控股近期收入的下降值得深思。或许市场认为近期的收入表现不足以跟上行业，导致市销率受到影响。看好万嘉集团控股的人希望这不是事实，以便他们能够以较低的估值买入该股票。</p>
</div><p>Want the full picture on earnings, revenue and cash flow for the company? Then our <strong>free</strong> report on Wanjia Group Holdings will help you shine a light on its historical performance.</p>
<div class="lb-trans"><p>想要了解公司收益、收入和现金流的完整情况吗？那么我们 <strong>免费的</strong> 万嘉集团控股报告将帮助您了解其历史表现。</p>
</div><h2>Do Revenue Forecasts Match The Low P/S Ratio?</h2>
<div class="lb-trans"><h2>收入预测是否与低市销率相匹配？</h2>
</div><p>The only time you'd be truly comfortable seeing a P/S as low as Wanjia Group Holdings' is when the company's growth is on track to lag the industry.</p>
<div class="lb-trans"><p>您唯一会真正感到舒适的情况是，当公司的增长预计将落后于行业时，才会看到像万嘉集团控股这样低的市销率。</p>
</div><p>In reviewing the last year of financials, we were disheartened to see the company's revenues fell to the tune of 4.5%. This means it has also seen a slide in revenue over the longer-term as revenue is down 6.3% in total over the last three years. Therefore, it's fair to say the revenue growth recently has been undesirable for the company.</p>
<div class="lb-trans"><p>在回顾过去一年的财务数据时，我们感到沮丧，因为公司的收入下降了 4.5%。这意味着在长期内收入也出现了下滑，过去三年总收入下降了 6.3%。因此，可以公平地说，最近的收入增长对公司来说是不理想的。</p>
</div><p>Comparing that to the industry, which is predicted to deliver 9.2% growth in the next 12 months, the company's downward momentum based on recent medium-term revenue results is a sobering picture.</p>
<div class="lb-trans"><p>与行业相比，预计在未来 12 个月内将实现 9.2% 的增长，该公司的近期中期收入结果显示出下行趋势，形成了一个令人警醒的局面。</p>
</div><p>With this in mind, we understand why Wanjia Group Holdings' P/S is lower than most of its industry peers. However, we think shrinking revenues are unlikely to lead to a stable P/S over the longer term, which could set up shareholders for future disappointment. There's potential for the P/S to fall to even lower levels if the company doesn't improve its top-line growth.</p>
<div class="lb-trans"><p>考虑到这一点，我们理解为什么万嘉集团控股的市销率低于大多数行业同行。然而，我们认为收入的萎缩不太可能在长期内导致稳定的市销率，这可能使股东面临未来的失望。如果公司不改善其收入增长，市销率甚至可能降至更低水平。</p>
</div><h2>What We Can Learn From Wanjia Group Holdings' P/S?</h2>
<div class="lb-trans"><h2>我们可以从万嘉集团控股的市销率中学到什么？</h2>
</div><p>Wanjia Group Holdings' recently weak share price has pulled its P/S back below other Healthcare companies. While the price-to-sales ratio shouldn't be the defining factor in whether you buy a stock or not, it's quite a capable barometer of revenue expectations.</p>
<div class="lb-trans"><p>万嘉集团控股最近疲软的股价使其市销率低于其他医疗公司。虽然市销率不应成为您是否购买股票的决定性因素，但它是收入预期的一个相当有效的晴雨表。</p>
</div><p>As we suspected, our examination of Wanjia Group Holdings revealed its shrinking revenue over the medium-term is contributing to its low P/S, given the industry is set to grow. Right now shareholders are accepting the low P/S as they concede future revenue probably won't provide any pleasant surprises either. If recent medium-term revenue trends continue, it's hard to see the share price moving strongly in either direction in the near future under these circumstances.</p>
<div class="lb-trans"><p>正如我们所怀疑的，我们对万嘉集团控股的审查显示，其中期收入的萎缩正在导致其市销率低，考虑到行业预计将增长。目前，股东接受低市销率，因为他们承认未来的收入可能也不会带来任何令人愉快的惊喜。如果近期的中期收入趋势持续下去，在这种情况下，很难看到股价在短期内有强劲的波动。</p>
</div><p>Plus, you should also learn about these <strong>3 warning signs we've spotted with Wanjia Group Holdings</strong>.</p>
<div class="lb-trans"><p>此外，您还应该了解我们发现的 <strong>万嘉集团控股的 3 个警示信号</strong>。</p>
</div><p>If these <strong>risks are making you reconsider your opinion on Wanjia Group Holdings</strong>, explore our interactive list of high quality stocks to get an idea of what else is out there.</p>
<div class="lb-trans"><p>如果这些 <strong>风险让您重新考虑对万嘉集团控股的看法</strong>，请查看我们的高质量股票互动列表，以了解还有哪些其他选择。</p>
</div><p>Mobile Infrastructure for Defense and Disaster</p>
<div class="lb-trans"><p>移动基础设施用于国防和灾难</p>
</div><p>The next wave in robotics isn't humanoid. Its fully autonomous towers delivering 5G, ISR, and radar in under 30 minutes, anywhere.</p>
<div class="lb-trans"><p>下一波机器人技术不是类人型的。它是完全自主的塔楼，在 30 分钟内提供 5G、ISR 和雷达，随时随地。</p>
</div><p>Get the investor briefing before the next round of contracts</p>
<div class="lb-trans"><p>在下一轮合同之前获取投资者简报</p>
</div><p>Sponsored On Behalf of CiTech</p>
<div class="lb-trans"><p>代表 CiTech 赞助</p>
</div>

万嘉集团控股有限公司（HKG:401）的收入未能引起太多关注，股价暴跌 27%